GSH‐Responsive Semiconducting Polymer as a Nanotheranostic Platform for NIR‐II Imaging‐Guided Chemo‐Photothermal Therapy
Macromolecular Rapid Communications · 2025
DOI: 10.1002/marc.202401098 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Rapid Communications, 2025. Verfasst von Ben Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Flexible Electronics (LoFE), Jiangsu Key Laboratory of Smart Biomaterials and Theranostic Technology, Institute of Advanced M…. Hauptthemen laut MEDLINE: Doxorubicin, Glutathione, Polymers, Photothermal Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Project of Jiangsu Specially-Appointed Professor, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
The development of multifunctional nanotheranostic platforms with stimuli‐responsive capabilities holds significant potential for enhancing cancer diagnosis and treatment. Herein, a glutathione (GSH)‐responsive semiconducting polymer (SP) nanotheranostic system, SP/DOX‐SS‐PEG nanoparticles (NPs), is presented, designed for combined near‐infrared II (NIR‐II) fluorescence imaging (FI) and chemo‐photothermal therapy. The amphiphilic SP (SP‐SS‐PEG) is synthesized through a multi‐step reaction sequence, including Suzuki coupling, amidation, and thiol‐disulfide exchange reactions, and subsequently encapsulates the anticancer drug doxorubicin (DOX) through self‐assembly, resulting in the formation of GSH‐responsive SP/DOX‐SS‐PEG NPs. These SP/DOX‐SS‐PEG NPs exhibit high photothermal stability and significant GSH‐triggered DOX release. In vitro studies demonstrate that SP/DOX‐SS‐PEG NPs display enhanced cellular uptake and robust cytotoxicity against 4T1 cancer cells under 808 nm laser irradiation. Upon intravenous injection in tumor‐bearing mice, NIR‐II FI reveals efficient tumor accumulation and prolonged retention of the NPs. In vivo anti‐tumor efficacy studies indicate that SP/DOX‐SS‐PEG NPs combined with 808 nm laser irradiation achieve the most significant inhibition of tumor growth, with minimal systemic toxicity. Taken together, these findings highlight the promising potential of SP/DOX‐SS‐PEG NPs as a multifunctional platform for precision cancer theranostics, integrating efficient NIR‐II imaging, GSH‐triggered drug release, and dual chemo‐photothermal therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Flexible Electronics (LoFE), Jiangsu Key Laboratory of Smart Biomaterials and Theranostic Technology, Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Adva…
Förderung
- National Natural Science Foundation of China
- Project of Jiangsu Specially-Appointed Professor
- Natural Science Foundation of Jiangsu Province
- Natural Science Foundation of the Jiangsu Higher Education Institutions of China
- Natural Science Research Start-up Foundation of Recruiting Talents of Nanjing University of Posts and Telecommunications
Zitieren
APA
Wang, B., Zhang, Y., Ji, Y., Yang, G., Zhang, X., Zhou, Y., Yu, S., Yin, H., Zhou, H., Yin, C., & Fan, Q. (2025). GSH‐Responsive Semiconducting Polymer as a Nanotheranostic Platform for NIR‐II Imaging‐Guided Chemo‐Photothermal Therapy. Macromolecular Rapid Communications. https://doi.org/10.1002/marc.202401098
Vancouver
Wang B, Zhang Y, Ji Y, Yang G, Zhang X, Zhou Y, et al. GSH‐Responsive Semiconducting Polymer as a Nanotheranostic Platform for NIR‐II Imaging‐Guided Chemo‐Photothermal Therapy. Macromolecular Rapid Communications. 2025. doi:10.1002/marc.202401098
BibTeX
@article{Wang2025,
author = {Wang, Ben and Zhang, Yujing and Ji, Yuquan and Yang, Guangzhao and Zhang, Xiaolong and Zhou, Yi and Yu, Siyang and Yin, Haotong and Zhou, Hui and Yin, Chao and Fan, Quli},
title = {GSH‐Responsive Semiconducting Polymer as a Nanotheranostic Platform for NIR‐II Imaging‐Guided Chemo‐Photothermal Therapy},
journal = {Macromolecular Rapid Communications},
year = {2025},
doi = {10.1002/marc.202401098}
}
EUVIMED